Executive Order Seeks to Build Resilience in Pharmaceutical Supply Chains

Start
On August 13, 2025, President Trump signed an executive order aimed at strengthening America’s pharmaceutical supply chains. Officially titled “Ensuring American Pharmaceutical Supply Chain Resilience by Filling the Strategic Active Pharmaceutical Ingredients Reserve,” the measure revives directives from a similar order in his first administration….
By: Carlton Fields
Previous Story

DOJ Settles Cyber Qui Tam Action Against Illumina for Allegedly Unsecured Genomic Sequencing Products

Next Story

The State of Ransomware in Retail 2025